Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
Anticancer agents that target both tumor cells and angiogenesis are of potential interest for glioblastoma (GB) therapy. One such agent is sorafenib (SFN), a tyrosine kinase inhibitor. However, poor aqueous solubility and undesirable side effects limit its clinical application, including local treat...
Tallennettuna:
Päätekijät: | Anne Clavreul (Tekijä), Emilie Roger (Tekijä), Milad Pourbaghi-Masouleh (Tekijä), Laurent Lemaire (Tekijä), Clément Tétaud (Tekijä), Philippe Menei (Tekijä) |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz
Tekijä: Grady K. Mukubwa, et al.
Julkaistu: (2022) -
In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives
Tekijä: Amr Selim Abu Lila, et al.
Julkaistu: (2023) -
Frontal aslant tract in the non-dominant hemisphere: A systematic review of anatomy, functions, and surgical applications
Tekijä: Clémentine Gallet, et al.
Julkaistu: (2022) -
Characterization and quantification of the interaction between the NFL-TBS.40‐63 peptide and lipid nanocapsules
Tekijä: A. Griveau, et al.
Julkaistu: (2022) -
Formulation development, characterization, and evaluation of sorafenib-loaded PLGA-chitosan nanoparticles
Tekijä: Abdul Mateen, et al.
Julkaistu: (2024)